We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
9 own
3 watching
Current Price
$22.12
$-0.01
(-0.05%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
1,068.29M
52-Week High
48.99
52-Week Low
11.41
Average Volume
0.62M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,068.29M
52-Week High48.99
52-Week Low11.41
Average Volume0.62M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Outset is a rapidly growing medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Outset believe the Tablo Hemodialysis System (Tablo) represents a significant technological advancement enabling novel, transformational dialysis care in acute and home settings Subsequently, on March 31, 2020, Tablo was cleared by the FDA for patient use in the home, and we are in the early stages of commercializing in the home market. --- We were incorporated in the state of Delaware in 2003 under the name Home Dialysis Plus, Ltd. We changed our name to Outset Medical, Inc. in 2015. Our principal executive offices are located at 3052 Orchard Drive, San Jose, California 95134, and our telephone number is (669) 231-8200. Our website address is www.outsetmedical.com.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Business Wire
5days ago
Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a virtual panel discussion at the BofA Securities Home Care Conference on...
Business Wire
17days ago
Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced it ranked 33 on the Deloitte Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life...
Zolmax
20days ago
Outset Medical (NASDAQ:OM Get Rating) had its price objective lowered by Cowen from $33.00 to $22.00 in a research note released on Wednesday, The Fly reports. Other equities analysts have also recently issued reports about the stock. The Goldman Sachs Group reduced their price objective on shares ...
Ticker Report
20days ago
Outset Medical (NASDAQ:OM Get Rating) had its price objective lowered by Cowen from $33.00 to $22.00 in a research note released on Wednesday, The Fly reports. Other equities analysts have also recently issued reports about the stock. The Goldman Sachs Group reduced their price objective on ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$22.12
$-0.01
(-0.05%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00